| Betterchem |

|
|
| FDA approval activities
for this prescription drug:
Alrex (Loteprednol Etabonate) Ophthalmic Suspension, 0.2% Bausch and Lomb NDA 20803 Lotemax (Loteprednol Etabonate), 0.5% Bausch and Lomb NDA 20-841 3/9/98 3/9/98 6/25/98 4/11/02 Lotemax (Loteprednol Etabonate), Ophthalmic Suspension, 0.5% Pharmos NDA 20-583 |
|
© 2009 Betterchem.com
|